Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor

The rapid structural evolution and emergence of novel synthetic cannabinoid receptor agonists (SCRAs) in the recreational market remains a key public health concern. Despite representing one of the largest classes of new psychoactive substances, pharmacological data on new SCRAs is limited, particul...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Monica, Grimsey, Natasha L., Banister, Samuel D., Finlay, David B., Glass, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685394/
https://www.ncbi.nlm.nih.gov/pubmed/38018694
http://dx.doi.org/10.1002/prp2.1157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685394/
https://www.ncbi.nlm.nih.gov/pubmed/38018694
http://dx.doi.org/10.1002/prp2.1157

Ejemplares similares